Second antibiotic no advantage for treating super–bug Golden Staph

Feb 13, 2020
A world–first clinical trial has called into question the effectiveness of using more than one antibiotic to treat the deadly 'super–bug', Methicillin–resistant staphylococcus aureus (MRSA) Bacteremia, commonly known as Golden Staph.

Other news

Cookies help us deliver our services. By using our services, you agree to our use of cookies.